Latest Amyotrophic lateral sclerosis Stories
GERMANTOWN, Md., Nov. 7, 2014 /PRNewswire/ -- Neuralstem, Inc.
Dr. Hefti to Lead All Clinical Development Efforts and Strategic Initiatives CAMBRIDGE, Mass., Nov.
Board of Trustees Approves Integrated, Collaborative Approach WASHINGTON, Oct.
The Centers for Disease Control and Prevention (CDC) selects DRT Strategies as the prime contractor to provide technical, database, and user experience support to the National ALS Registry.
Agencies Award Four Grants to Advance Study of Frontotemporal Degeneration RADNOR, Pa., Oct.
Local CITGO Marketer Sponsors MDA Toast to Life Gala APPLETON, Wis., Oct.
LOS ANGELES, Oct.
Expected to Yield First Clinical Candidate in 2015 LOS ANGELES, Oct.
NSI-566 to be Tested in Four Patients with Chronic Spinal Cord Injury GERMANTOWN, Md., Oct. 9, 2014 /PRNewswire/ -- Neuralstem, Inc.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.